Related Experiment Videos
Libido, menopause, and estrogen replacement therapy
1Clinical Faculty, University of Utah School of Medicine, Salt Lake City.
Postgraduate Medicine
|July 1, 1989
Summary
Many women hesitate to discuss decreased sexual desire with doctors. This study suggests specific questioning and hormone replacement therapy for sexual dysfunction due to genitourinary atrophy or low estrogen.
Area of Science:
- Reproductive Medicine
- Women's Health
- Endocrinology
Background:
- Patient reluctance to discuss sexual concerns with physicians is common.
- Sexual dysfunction can significantly impact quality of life.
- Decreased libido may be linked to hormonal changes in women.
Purpose of the Study:
- To highlight the importance of physician-initiated inquiry into sexual dysfunction.
- To propose a treatment approach for specific types of female sexual dysfunction.
- To address sexual dysfunction secondary to genitourinary atrophy and declining estrogen levels.
Main Methods:
- Recommending specific patient questioning to identify sexual dysfunction symptoms.
- Outlining a hormone replacement therapy (HRT) program.
- Targeting HRT for women with genitourinary atrophy and loss of libido.
Main Results:
- Physician-led questioning can effectively elicit patient concerns about sexual dysfunction.
- Hormone replacement therapy is presented as a viable treatment option.
- The study provides a framework for managing estrogen-related sexual dysfunction.
Conclusions:
- Proactive physician inquiry is crucial for addressing female sexual dysfunction.
- Hormone replacement therapy offers a potential solution for specific patient groups.
- Managing genitourinary atrophy and estrogen decline can improve sexual health in women.